Difficulty: Medium
Average Score: 85%
Practice
The most definite beneficial results are obtained in the use of anticoagulants for the following purpose
Correct answer
B
Rationale
In the context of hematological drugs, the most definite beneficial results are obtained in the use of anticoagulants for the purpose of preventing venous thrombosis and pulmonary embolism (option B). Anticoagulants like heparin and warfarin work by inhibiting the clotting cascade, thus reducing the risk of blood clots forming in veins and traveling to the lungs, which can result in life-threatening pulmonary embolism.
Option A, prevention of recurrences of myocardial infarction, is not the primary indication for anticoagulant therapy. While anticoagulants may be used in some cases post-myocardial infarction, antiplatelet agents like aspirin are typically the first-line therapy for this purpose.
Option C, cerebrovascular accident (stroke), is more commonly managed with antiplatelet drugs like aspirin or anticoagulants in specific cases of atrial fibrillation, not necessarily as a primary indication for anticoagulant therapy.
Option D, retinal artery thrombosis, is a rare condition where there is a blockage in the retinal artery. Anticoagulants may be considered in some cases, but the primary treatment revolves around addressing underlying conditions like hypertension or hypercholesterolemia.
In an educational context, understanding the specific indications for different classes of drugs is crucial for healthcare professionals to provide optimal patient care. Knowing when to use anticoagulants versus antiplatelet agents in various clinical scenarios can significantly impact patient outcomes and reduce the risk of adverse events. It is essential for healthcare providers to be well-versed in the pharmacological management of hematological conditions to make informed and effective treatment decisions.
Option A, prevention of recurrences of myocardial infarction, is not the primary indication for anticoagulant therapy. While anticoagulants may be used in some cases post-myocardial infarction, antiplatelet agents like aspirin are typically the first-line therapy for this purpose.
Option C, cerebrovascular accident (stroke), is more commonly managed with antiplatelet drugs like aspirin or anticoagulants in specific cases of atrial fibrillation, not necessarily as a primary indication for anticoagulant therapy.
Option D, retinal artery thrombosis, is a rare condition where there is a blockage in the retinal artery. Anticoagulants may be considered in some cases, but the primary treatment revolves around addressing underlying conditions like hypertension or hypercholesterolemia.
In an educational context, understanding the specific indications for different classes of drugs is crucial for healthcare professionals to provide optimal patient care. Knowing when to use anticoagulants versus antiplatelet agents in various clinical scenarios can significantly impact patient outcomes and reduce the risk of adverse events. It is essential for healthcare providers to be well-versed in the pharmacological management of hematological conditions to make informed and effective treatment decisions.